Aadi Bioscience (AADI) Stock Statistics & Valuation Metrics

Aadi Bioscience has a market cap or net worth of $50.63M. The enterprise value is ―.

Aadi Bioscience has 24,696,568 shares outstanding. The number of shares has decreased by -2.65% in one year.

Aadi Bioscience’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Aadi Bioscience is -0.83. Aadi Bioscience’s PEG ratio is -0.13.

In the last 12 months, Aadi Bioscience had revenue of 24.35M and earned -65.77M in profits. Earnings per share was -2.44.

In the last 12 months, operating cash flow was -61.20M and capital expenditures 170.00K, giving a free cash flow of -61.03M billion.

Aadi Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―

Aadi Bioscience upcoming earnings date is May 7, 2025, TBA Not Confirmed.

Aadi Bioscience as a current ratio of 4.72, with Debt / Equity ratio of 1.37%

In the past 12 months, Aadi Bioscience has paid 0.00 in taxes.

Aadi Bioscience EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Aadi Bioscience has $62.62M in cash and marketable securities with $946.00K in debt, giving a net cash position of -$61.67M billion.

Gross margin is 87.39%, with operating margin of -295.36%, and net profit margin of -270.04%.

The average price target for Aadi Bioscience is ―, which is 11.43% higher than the current price. The consensus rating is ―